BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15764682)

  • 1. Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor.
    Bridgman P; Aronovitz MA; Kakkar R; Oliverio MI; Coffman TM; Rand WM; Konstam MA; Mendelsohn ME; Patten RD
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H586-92. PubMed ID: 15764682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
    Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
    Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmitral inflow pattern assessed by Doppler echocardiography in angiotensin II type 1A receptor knockout mice with myocardial infarction.
    Nakamura Y; Yoshiyama M; Omura T; Yoshida K; Kim S; Takeuchi K; Iwao H; Yoshikawa J
    Circ J; 2002 Feb; 66(2):192-6. PubMed ID: 11999647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction.
    Harada K; Sugaya T; Murakami K; Yazaki Y; Komuro I
    Circulation; 1999 Nov; 100(20):2093-9. PubMed ID: 10562266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart.
    Li Y; Takemura G; Okada H; Miyata S; Kanamori H; Maruyama R; Esaki M; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H946-53. PubMed ID: 17028164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling.
    Oishi Y; Ozono R; Yano Y; Teranishi Y; Akishita M; Horiuchi M; Oshima T; Kambe M
    Hypertension; 2003 Mar; 41(3 Pt 2):814-8. PubMed ID: 12624001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
    Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
    Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
    Trueblood NA; Xie Z; Communal C; Sam F; Ngoy S; Liaw L; Jenkins AW; Wang J; Sawyer DB; Bing OH; Apstein CS; Colucci WS; Singh K
    Circ Res; 2001 May; 88(10):1080-7. PubMed ID: 11375279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction.
    Katada J; Meguro T; Saito H; Ohashi A; Anzai T; Ogawa S; Yoshikawa T
    Circulation; 2005 May; 111(17):2157-64. PubMed ID: 15851599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
    Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
    Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
    Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
    Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
    Niizeki T; Takeishi Y; Arimoto T; Takahashi H; Shishido T; Koyama Y; Goto K; Walsh RA; Kubota I
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1105-12. PubMed ID: 17071729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
    Ambrose J; Pribnow DG; Giraud GD; Perkins KD; Muldoon L; Greenberg BH
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-myocardial infarction left ventricular myocyte remodeling: are there gender differences in rats?
    Chen YF; Redetzke RA; Sivertson RM; Coburn TS; Cypher LR; Gerdes AM
    Cardiovasc Pathol; 2011; 20(5):e189-95. PubMed ID: 21081276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
    Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction.
    Sam F; Sawyer DB; Xie Z; Chang DL; Ngoy S; Brenner DA; Siwik DA; Singh K; Apstein CS; Colucci WS
    Circ Res; 2001 Aug; 89(4):351-6. PubMed ID: 11509452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin protects against the development of systolic dysfunction following myocardial infarction.
    Shibata R; Izumiya Y; Sato K; Papanicolaou K; Kihara S; Colucci WS; Sam F; Ouchi N; Walsh K
    J Mol Cell Cardiol; 2007 Jun; 42(6):1065-74. PubMed ID: 17499764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling.
    Isbell DC; Voros S; Yang Z; DiMaria JM; Berr SS; French BA; Epstein FH; Bishop SP; Wang H; Roy RJ; Kemp BA; Matsubara H; Carey RM; Kramer CM
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3372-8. PubMed ID: 17933966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.